Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. Delivering innovative medicines to patients with serious or life-threatening medical conditions is what Genentech is all about. Today, Genentech manufactures and commercializes 10 protein-based products for serious or life-threatening medical conditions -- giving Genentech one of the leading product portfolios in the biotech industry. Our focus is on developing innovative therapies that fill significant unmet medical needs and positively impact the world of human health. Genentech currently manufactures and commercializes 12 products in the United States for a variety of medical conditions, including cancer, heart attack, allergic asthma, psoriasis, stroke, growth hormone deficiency and cystic fibrosis.